Among older adults with normal blood pressure, replacing table salt with salt substitute reduced the incidence of hypertension vs a usual salt group, in the DECIDE-Salt trial.
US buyout fund Platinum Equity Advisors is in talks to acquire Mumbai-based contract drugmaker Inventia Healthcare at a valuation of ₹2,500 crore ($300 million). Existing investors InvAscent Capital and Jacob Ballas are set to exit their investments while promoter Janak Shah and family will retain a minority stake. Post the transaction, the promoter family intends to continue leading the company. Rothschild & Co and Stifel Financial Corp are running the sale process of Inventia.
Palo Alto Networks Revolutionizes Cloud Security With Industry-First Integrated Code To Cloud Intelligence menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.